Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues

Breast. 2015 Nov:24 Suppl 2:S108-13. doi: 10.1016/j.breast.2015.07.025. Epub 2015 Aug 3.

Authors

John Yarnold¹, Navita Somaiah², Judith M Bliss³

Affiliations

¹ Division of Radiotherapy and Imaging, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. Electronic address: john.yarnold@icr.ac.uk.
² Division of Radiotherapy and Imaging, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK.
³ Clinical Trials and Statistic Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK.

PMID: 26249121
DOI: 10.1016/j.breast.2015.07.025

No abstract available

Keywords: Breast cancer; Clinical trials; Hypofractionation; Radiotherapy.

MeSH terms

Adult
Aged
Breast / anatomy & histology*
Breast Neoplasms / genetics
Breast Neoplasms / pathology
Breast Neoplasms / radiotherapy*
Breast Neoplasms / surgery
Canada
DNA Damage / radiation effects
DNA End-Joining Repair
Female
Humans
Intraoperative Care
Middle Aged
Organ Size
Radiation Dose Hypofractionation*
Radiotherapy, Adjuvant
Radiotherapy, Intensity-Modulated
Randomized Controlled Trials as Topic
United Kingdom

Grants and funding